Company Filing History:
6 out of 5,081 
5 out of 1,743 
5 out of 290 
Years Active: 2017-2022
Title: Laure Boudier: Innovator in Monoclonal Antibodies
Introduction
Laure Boudier is a prominent inventor based in Saint-Yorre, France, known for her significant contributions to the field of biomedical research. With a total of six patents to her name, she has made remarkable strides in the development of monoclonal antibodies, particularly in relation to colorectal cancer.
Latest Patents
Among her latest patents, Boudier has focused on monoclonal antibodies to progastrin and their various applications. The disclosures detail progastrin monoclonal antibodies, their fragments, and compositions that include these antibodies. Furthermore, her work outlines methods for treating colorectal cancer using these antibodies and compositions. The patents also encompass techniques for detecting progastrin, which are crucial for diagnosing colorectal cancer and monitoring the effectiveness of anti-cancer therapies in affected individuals.
Career Highlights
Boudier has had a distinguished career, working with esteemed institutions such as the Centre National de la Recherche Scientifique and the Institut National de la Santé et de la Recherche Médicale. Her research has not only advanced scientific understanding but has also paved the way for innovative treatment options in oncology.
Collaborations
Throughout her career, Boudier has collaborated with notable colleagues, including Julie Pannequin and Dominique Joubert. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in the